Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.50% | 43.97 | 0.9% | $1186.44m | |
| ABBV | AbbVie, Inc. | -0.22% | 107.12 | 1.9% | $1023.77m | |
| JNJ | Johnson & Johnson | -0.23% | 164.48 | 0.7% | $988.09m | |
| MRK | Merck & Co., Inc. | 0.81% | 73.64 | 0.7% | $914.30m | |
| LLY | Eli Lilly & Co. | -0.26% | 231.58 | 1.1% | $588.95m | |
| BMY | Bristol-Myers Squibb Co. | -0.61% | 60.26 | 1.0% | $575.61m | |
| AZN | AstraZeneca Plc | 1.46% | 60.35 | 1.0% | $353.10m | |
| NVS | Novartis AG | -0.75% | 82.95 | 0.2% | $156.40m | |
| CRVS | Corvus Pharmaceuticals, Inc. | -3.27% | 6.80 | 0.7% | $140.27m | |
| GSK | GlaxoSmithKline Plc | -2.44% | 38.38 | 0.2% | $135.32m | |
| RGEN | Repligen Corp. | -0.29% | 323.26 | 6.8% | $123.14m | |
| SNY | Sanofi | -1.60% | 47.94 | 0.2% | $122.20m | |
| RPRX | Royalty Pharma Plc | -0.08% | 37.10 | 0.1% | $121.13m | |
| VTRS | Viatris, Inc. | 0.30% | 13.38 | 0.0% | $107.54m | |
| NVO | Novo Nordisk A/S | -1.36% | 100.71 | 0.1% | $101.76m |
Company Profile
Nektar Therapeutics is a research-based biopharmaceutical company that focuses on discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and auto-immune disease. The company was founded in 1990 and is headquartered in San Francisco, CA.